Related Experiment Videos

[Adriamycin--breast cancer]

¹Dept. of Breast Surgery, National Kyushu Cancer Center.

Gan to Kagaku Ryoho. Cancer & Chemotherapy

|December 1, 1996

Summary

Doxorubicin (ADR) remains a key drug for breast cancer treatment, showing 40-60% response rates. Predictive factors for advanced cases include metastasis site and performance status, influencing survival.

Area of Science:

Oncology
Pharmacology
Clinical Medicine

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Interleukin-8 is a major neutrophil chemotactic factor derived from cultured human gingival fibroblasts stimulated with interleukin-1 beta or tumor necrosis factor alpha.

Infection and immunity·1992

Pituitary dependent hyperadrenocorticism in a cat.

The Journal of veterinary medical science·1992

[Clinical study of total parathyroidectomy and autotransplantation for secondary hyperparathyroidism].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·1992

Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer. 5-Year results from the Nishi-Nippon Group of the Adjuvant Chemoendocrine Therapy for Breast Cancer Organization.

Cancer·1992

[Aminoglutethimide and aminoglutethimide+tamoxifen treatment for advanced breast cancer].

Gan to kagaku ryoho. Cancer & chemotherapy·1992

Action of a nuclease from rat nuclei on UV-irradiated DNA.

Biochemistry international·1992

See all related articles